Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:15 PM
Ignite Modification Date:
2025-12-25 @ 7:49 PM
NCT ID:
NCT02362035
Group ID:
EG000
Title:
Acalabrutinib + Pembrolizumab
Description:
All participants in this study received both study drugs and were therefore analysed together as a single treatment arm.
Participants receiving the different regimens were not analysed separately by regimen, as the study was designed to assess the safety of the combination study treatment.
The study included N=161 participants who received both acalabrutinib and pembrolizumab and are summarized together (from First stage safety lead-in and Second stage expansion). Stage 3 (additional expansion in subjects with Myelofibrosis) was planned but not conducted.
Deaths Number Affected:
69
Deaths Number At Risk:
None
Serious Number Affected:
75
Serious Number At Risk:
161
Other Number Affected:
157
Other Number At Risk:
161
Study:
NCT02362035
Results Section:
NCT02362035
Adverse Events Module:
NCT02362035